Hearing Aids Manufacturing: A Sustainable Oligopoly?
Former Managing Director, Sivantos
inpractise.com/articles/hearing-aids-oligopoly
Why is this interview interesting?
- The pros and cons of vertical integration for OEMs
- How barriers to entry to the hearing aids OEM market have evolved over the last 20 years
- Threat of new entrants: Apple & Samsung
- Reasons average selling prices for hearing aids would further erode in the coming years
Hearing Aids Manufacturing: A Sustainable Oligopoly?(September 2, 2020)
Robin Hees
Former Managing Director, Sivantos
Robin spent over 15 years in the hearing aids industry, starting as a salesperson in the hearing instrument wholesale business for Siemens Audiologische Technik (Now WS Audiology). His service at Siemens’ hearing aids business culminated in the role of Managing Director for 5 years, from 2011-16. He is currently the CFO of Method Park, a fast-growing software engineering consultancy headquartered in Germany.
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2023 IP 1 Ltd. All rights reserved.